Il Yang Pharmaceutical Co Ltd
007570
Company Profile
Business description
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.
Contact
110, hagal-ro, Giheung-gu
Yongin-si
SeoulGyeonggi
KORT: +82 312817851
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
668
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,954.60 | 8.90 | -0.10% |
| CAC 40 | 7,800.88 | 33.70 | -0.43% |
| DAX 40 | 23,970.36 | 247.14 | -1.02% |
| Dow JONES (US) | 44,837.56 | 64.36 | -0.14% |
| FTSE 100 | 9,081.44 | 38.87 | -0.43% |
| HKSE | 25,295.21 | 266.92 | -1.04% |
| NASDAQ | 21,178.58 | 70.27 | 0.33% |
| Nikkei 225 | 40,599.19 | 399.08 | -0.97% |
| NZX 50 Index | 12,936.41 | 25.67 | 0.20% |
| S&P 500 | 6,389.77 | 1.13 | 0.02% |
| S&P/ASX 200 | 8,693.40 | 4.30 | -0.05% |
| SSE Composite Index | 3,596.11 | 1.83 | -0.05% |